Health Care [ 9/12 ] | Biotechnology [ 36/73 ]
NASDAQ | Common Stock
Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.
It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.
The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022.
Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 8, 25 | -7.01 Decreased by -36.65% | -9.00 Increased by +22.11% |
| May 8, 25 | -2.11 Increased by +14.23% | -6.88 Increased by +69.33% |
| Mar 20, 25 | -4.98 Increased by +40.22% | -10.32 Increased by +51.74% |
| Nov 7, 24 | -0.84 Decreased by -100.00% | -2.84 Increased by +70.42% |
| Aug 9, 24 | -5.13 Decreased by -1.95 K% | -1.80 Decreased by -185.00% |
| May 10, 24 | -2.46 Decreased by -188.17% | -5.38 Increased by +54.28% |
| Mar 22, 24 | -8.33 Decreased by -392.90% | -13.77 Increased by +39.51% |
| Nov 9, 23 | -0.42 Increased by +80.00% | -0.30 Decreased by -40.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 0.00 Decreased by N/A% | -2.44 M Increased by +70.87% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -2.05 M Increased by +23.50% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 26.96 K Decreased by -28.24% | -1.73 M Increased by +21.65% | Decreased by -6.40 K% Decreased by -9.18% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -2.24 M Increased by +14.69% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -8.39 M Decreased by -479.42% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -2.68 M Decreased by -143.53% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 37.57 K Increased by +N/A% | -2.20 M Decreased by -82.37% | Decreased by -5.86 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -2.63 M Decreased by -124.47% | Decreased by N/A% Decreased by N/A% |